4//SEC Filing
Bazarko Daniel 4
Accession 0000899866-20-000096
CIK 0000899866other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 5:10 PM ET
Size
8.0 KB
Accession
0000899866-20-000096
Insider Transaction Report
Form 4
Bazarko Daniel
SVP, Controller, CAO
Transactions
- Tax Payment
Common Stock, par value $.0001 per share
2020-12-16$157.96/sh−1,725$272,481→ 30,883 total - Award
Common Stock, par value $.0001 per share
2020-12-16+15,371→ 39,695 total - Tax Payment
Common Stock, par value $.0001 per share
2020-12-16$157.96/sh−7,087$1,119,463→ 32,608 total
Footnotes (3)
- [F1]Shares acquired on vesting of Performance Stock Units previously granted on February 28, 2018 under the 2017 Stock Incentive Plan.
- [F2]This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units.
- [F3]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
Documents
Issuer
ALEXION PHARMACEUTICALS, INC.
CIK 0000899866
Entity typeother
Related Parties
1- filerCIK 0001768214
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 5:10 PM ET
- Size
- 8.0 KB